Serotonin 2B Receptor Interactions with Dopamine Network: Implications for Therapeutics in Schizophrenia
| dc.rights.license | open | en_US |
| hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
| dc.contributor.author | CATHALA, Adeline | |
| hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
| dc.contributor.author | SPAMPINATO, Umberto | |
| dc.contributor.editor | SPRINGER | |
| dc.date.accessioned | 2022-04-04T13:05:38Z | |
| dc.date.available | 2022-04-04T13:05:38Z | |
| dc.date.issued | 2021 | |
| dc.identifier.isbn | 978-3-030-55920-5 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/136594 | |
| dc.description.abstractEn | The serotonin 2B receptor (5-HT2BR) is the most recent addition to the 5-HT2R family. During the last decade, a growing number of studies have shown that the central 5-HT2BR participates in the control of serotonin (5-HT) and dopamine (DA) neuron activity and have underlined its potential for new therapeutic strategies for several neuropsychiatric disorders such as drug addiction, depression and schizophrenia. After reviewing the major advances in the identification and characterization of this receptor within the central nervous system, this chapter focuses on its functional role in the control of ascending DA pathway activity and on the mechanisms underlying this interaction, by covering electrophysiological, neurochemical and behavioral data mainly from in vivo studies in rats. Afterwards, the therapeutic relevance of 5-HT2BR antagonists for treating DA-dependent neuropsychiatric disorders is discussed by focusing on schizophrenia. | |
| dc.language.iso | EN | en_US |
| dc.publisher | Springer | en_US |
| dc.publisher.location | Cham | en_US |
| dc.source.title | 5-HT2B Receptors: from Molecular Biology to Clinical Applications | en_US |
| dc.subject.en | Dopamine | |
| dc.subject.en | Dorsal raphe nucleus | |
| dc.subject.en | Intracerebral microdialysis | |
| dc.subject.en | Medial prefrontal cortex | |
| dc.subject.en | Nucleus accumbens | |
| dc.subject.en | Rat | |
| dc.subject.en | Schizophrenia | |
| dc.subject.en | Serotonin | |
| dc.subject.en | Serotonin 2B receptor | |
| dc.title.en | Serotonin 2B Receptor Interactions with Dopamine Network: Implications for Therapeutics in Schizophrenia | |
| dc.type | Chapitre d'ouvrage | en_US |
| dc.identifier.doi | 10.1007/978-3-030-55920-5_19 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
| bordeaux.page | 323-333 | en_US |
| bordeaux.volume | 35 | en_US |
| bordeaux.hal.laboratories | Neurocentre Magendie - UMR-S 1215 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Institut National de la Santé et de la Recherche Médicale | en_US |
| bordeaux.identifier.funderID | Université de Bordeaux | en_US |
| hal.identifier | hal-03629706 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-04-04T13:05:40Z | |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.btitle=5-HT2B%20Receptors:%20from%20Molecular%20Biology%20to%20Clinical%20Applications&rft.date=2021&rft.volume=35&rft.spage=323-333&rft.epage=323-333&rft.au=CATHALA,%20Adeline&SPAMPINATO,%20Umberto&rft.isbn=978-3-030-55920-5&rft.genre=unknown |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||